VolitionRx Ltd (VNRX) stock
VNRXNYSEIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$0.20−0.03 (-13.13%)
Close on Nov 16, 2026Market cap $2.73MP/E –Yield –
VolitionRx profit margin
Profit margin (net margin) is net income as a percentage of revenue.
VolitionRx's profit margin for the twelve months ending Jun 30, 2026 was -1043.1%. For fiscal 2025 it was -1352.2%, against -2186.3% the year before. The highest annual figure on record is -1352.2% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -1352.2% | +834.1 |
| FY2024 | Dec 31, 2024 | -2186.3% | +2415.4 |
| FY2023 | Dec 31, 2023 | -4601.7% | +5385.0 |
| FY2022 | Dec 31, 2022 | -9986.7% | +19990.3 |
| FY2021 | Dec 31, 2021 | -29977.0% | +121882.6 |
| FY2020 | Dec 31, 2020 | -151859.6% | −57691.0 |
| FY2019 | Dec 31, 2019 | -94168.5% | −38615.4 |
| FY2014 | Dec 31, 2014 | -55553.1% | −48125.1 |
| FY2012 | Dec 31, 2012 | -7428.0% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -1837.7% | −292.5 |
| Q1 FY2026 | Mar 31, 2026 | -676.6% | +1524.8 |
| Q4 FY2025 | Dec 31, 2025 | -1402.8% | +1620.0 |
| Q3 FY2025 | Sep 30, 2025 | -857.4% | +369.4 |
| Q2 FY2025 | Jun 30, 2025 | -1545.2% | +219.7 |
| Q1 FY2025 | Mar 31, 2025 | -2201.3% | +2676.6 |
| Q4 FY2024 | Dec 31, 2024 | -3022.8% | +584.1 |
| Q3 FY2024 | Sep 30, 2024 | -1226.8% | +3889.8 |
| Q2 FY2024 | Jun 30, 2024 | -1764.9% | +2650.6 |
| Q1 FY2024 | Mar 31, 2024 | -4877.9% | +1044.9 |
| Q4 FY2023 | Dec 31, 2023 | -3606.8% | +2521.2 |
| Q3 FY2023 | Sep 30, 2023 | -5116.6% | +18763.9 |
| Q2 FY2023 | Jun 30, 2023 | -4415.6% | +15035.1 |
| Q1 FY2023 | Mar 31, 2023 | -5922.9% | +834.8 |
| Q4 FY2022 | Dec 31, 2022 | -6128.0% | +50811.7 |
| Q3 FY2022 | Sep 30, 2022 | -23880.5% | +4301.0 |
| Q2 FY2022 | Jun 30, 2022 | -19450.6% | +3043.5 |
| Q1 FY2022 | Mar 31, 2022 | -6757.7% | +17235.9 |
| Q4 FY2021 | Dec 31, 2021 | -56939.8% | +15545.0 |
| Q3 FY2021 | Sep 30, 2021 | -28181.5% | +725896.4 |
| Q2 FY2021 | Jun 30, 2021 | -22494.1% | +74600.5 |
| Q1 FY2021 | Mar 31, 2021 | -23993.6% | +1053090.8 |
| Q4 FY2020 | Dec 31, 2020 | -72484.7% | −48029.9 |
| Q3 FY2020 | Sep 30, 2020 | -754077.9% | – |
| Q2 FY2020 | Jun 30, 2020 | -97094.6% | – |
| Q1 FY2020 | Mar 31, 2020 | -1077084.4% | – |
| Q3 FY2019 | Sep 30, 2019 | -24454.9% | – |
See a number that looks wrong?